Adjusting Injectable Contraceptive Use for Months Since the Last Injection

被引:0
|
作者
Karra, Mahesh [1 ]
Canning, David [2 ]
机构
[1] Boston Univ, Frederick S Pardee Sch Global Studies, 152 Bay State Rd,Room G04C, Boston, MA 02215 USA
[2] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave,SPH 11211,12th Floor, Boston, MA 02115 USA
关键词
contraception; injectables; Malawi; MEDROXYPROGESTERONE ACETATE; FERTILITY; RETURN;
D O I
10.1111/sifp.12256
中图分类号
C921 [人口统计学];
学科分类号
摘要
Injectables are one of the most popular methods of contraception worldwide, particularly in sub-Saharan Africa. An advantage of injectables over shorter-acting methods is that they provide additional flexibility by not requiring re-supply as frequently. However, there is a risk that injectable users may delay their next injection and may therefore have reduced or no protection from pregnancy. In surveys, women may report that they are using contraception in the form of injectables when the time since they had their last injection (more than four months) would imply that they have reduced protection against the risk of pregnancy. We carried out two field studies in urban Malawi, and we record reported injectable contraceptive use while also asking the number of months since women received their last injection. We observe that 13.8 percent of women who report using injectables also report that they received their last injection more than four months ago, and 11 percent report that they received their last injection more than six months ago. Our analysis highlights the need for additional follow-up with women who report using injectables in surveys to confirm whether they are, in fact, using the method effectively.
引用
收藏
页码:71 / 77
页数:7
相关论文
共 50 条
  • [21] Monthly injectable contraceptive use and cancer in female Shanghai textile workers.
    Rosenblatt, K
    Gao, DL
    Ray, RM
    Thomas, DB
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (11) : s73 - s73
  • [22] Immunosuppressive Biological Mechanisms Support Reassessment of Use of the Injectable Contraceptive Medroxyprogesterone Acetate
    Hapgood, Janet P.
    ENDOCRINOLOGY, 2013, 154 (03) : 985 - 988
  • [23] The Effect of Access to Contraceptive Services on Injectable Use and Demand for Family Planning in Malawi
    Skiles, Martha Priedeman
    Cunningham, Marc
    Inglis, Andrew
    Wilkes, Becky
    Hatch, Ben
    Bock, Ariella
    Barden-O'Fallon, Janine
    INTERNATIONAL PERSPECTIVES ON SEXUAL AND REPRODUCTIVE HEALTH, 2015, 41 (01) : 20 - 30
  • [24] RANDOMIZED CONTROLLED TRIAL OF CONTRACEPTIVE USE AT 3 AND 6 MONTHS POSTABORTION
    DePineres, T.
    Becker, D.
    Benitez, J.
    Gil, L.
    CONTRACEPTION, 2014, 89 (05) : 481 - 481
  • [25] Proposing a novel approach for the long-term use of monthly paliperidone palmitate: adjusting injection dose versus adjusting injection interval
    Sanchez-Alonso, Sergio
    Baca-Garcia, Enrique
    Ovejero, Santiago
    de Leon, Jose
    Schoretsanitis, Georgios
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2024, 20 (08) : 709 - 712
  • [26] Lunelle™ Monthly Contraceptive Injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension):: Effects of body weight and injection sites on pharmacokinetics
    Rahimy, MH
    Cromie, MA
    Hopkins, NK
    Tong, DM
    CONTRACEPTION, 1999, 60 (04) : 201 - 208
  • [27] THE INFLUENCE OF NURSE HOME VISITS, INCLUDING PROVISION OF 3 MONTHS OF CONTRACEPTIVES AND CONTRACEPTIVE COUNSELING, ON PERCEIVED BARRIERS TO CONTRACEPTIVE USE AND CONTRACEPTIVE USE SELF-EFFICACY
    Melnick, Alan L.
    Rdesinski, Rebecca E.
    Creach, E. Dawn
    Choi, Dongseok
    Harvey, S. Marie
    WOMENS HEALTH ISSUES, 2008, 18 (06) : 471 - 481
  • [28] Hospital and nursing home use in the last three months of life
    Brock, DB
    Foley, DJ
    Salive, ME
    JOURNAL OF AGING AND HEALTH, 1996, 8 (03) : 307 - 319
  • [29] Emergency Department Use by Older Adults in the Last Months of Life
    Smith, A. K.
    Cenzer, I. Stijacic
    McCarthy, E.
    Weber, E.
    Covinsky, K.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 : 2 - 2
  • [30] Patient acceptability and satisfaction with Lunelle™ Monthly Contraceptive Injection (medroxyprogesterone acetate and estradiol cypionate injectable suspension)
    Shulman, LP
    Oleen-Burkey, M
    Willke, RJ
    CONTRACEPTION, 1999, 60 (04) : 215 - 222